Thanks for the response. Certainly not my intention. However, it would be foolish to deny that there are thousands of traders out there looking at a sub $1 stock and taking a flyer on it if it is up 10% or whatever. I doubt they are on this message board trying to influence us, who know the stock the best.

What have we learned since Nader was terminated? We have a new CEO that shows some promise and we have a shareholders meeting scheduled for August 31st. That's it. Everything else is speculation or educated guesses. Sometime 2 plus 2 equals 4, but sometimes we only think it equals 4. However, it only equals 3. When that happens people get disappointed and they sell.

For what it's worth, my opinion is that CYDY is one of the best spec stocks available. With so many irons in the fire there are more chances for success. However, having been through this with other small biotechs, I would like to see the company narrow the focus to HIV, TNBC, Nash, and COVID, in that order. There just isn't enough money to do all the things that Nader PR'd. The best to you, ER.